The 20th edition of BioAsia – The Marquee Healthcare and Life Sciences event, organized by the Government of Telangana, has announced that the coveted Genome Valley Excellence Award for the year 2023 will be conferred upon Prof. Robert S. Langer, in light of his pioneering research that has led to the development of the first commercial mRNA vaccines used for a variety of infectious diseases. Langer is currently the David H. Koch Institute Professor at Massachusetts Institute of Technology (MIT), USA. He is also being acknowledged for his exemplary research in human health, including the detection, monitoring, and treatment of cancer. A veteran in his field, his remarkable contributions to biomedical and therapeutic research include developing long-term and controlled-release drug delivery systems used for a variety of applications including cancer therapy, insulin, and vaccines.
Press Release mail draft: Genome Valley Awards- Bio Asia 2023
Related Posts
edForce and SCRUMstudy Join Forces to Elevate Agile Training and Certification in India
Bengaluru, India, 18th May 2024 – edForce, a premier Workforce Upskilling Accelerator, is thrilled to announce its strategic partnership with SCRUMstudy, a globally recognized accreditation body for Scrum and Agile…
Unwind in Luxury: Fairmont Jaipur’s Exclusive Summer Escape
18th May 2024 – Fairmont Jaipur invites guests to indulge in the ultimate summer retreat with a unique staycation offer, where the guests can experience the cultural delights of their…